Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
TauRx Recognized as a Technology Innovation Leader in the Neurodegenerative Disease Management Industry 2019-06-11 08:00
Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device 2019-06-10 21:00
Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of "ACTEX" Product Commercialization 2019-06-10 20:00
Ping An Good Doctor Launches Groundbreaking 'Private Doctor' Service 2019-06-10 12:32
Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks 2019-06-08 23:45
ESPGHAN Researchers Warn: Junk Food Could Be Responsible for the Food Allergy Epidemic 2019-06-08 07:01
Asia's Leading Companies Celebrated at the 2019 Frost & Sullivan Asia-Pacific Best Practices Awards 2019-06-07 23:23
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal 2019-06-06 18:00
Innovent provides Update on the Results of Sintilimab for the Treatment of Extranodal NK/T Cell Lymphoma by Oral Presentation at ASCO 2019-06-05 08:00
RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2-Positive Metastatic or Unresectable Urothelial Cancer 2019-06-04 21:00
Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company 2019-06-04 20:17
Medtec China will expand to 2 Halls in 2020 for the first time 2019-06-04 19:11
Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma 2019-06-04 08:00
Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin's Lymphoma 2019-06-04 08:00
Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC) 2019-06-04 08:00
Merck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with METex14 Skipping Mutations 2019-06-04 02:16
Frost & Sullivan Publishes Q1 Update on Kadimastem 2019-06-03 21:24
Oxitec Successfully Completes First Field Deployment of 2nd Generation Friendly™ Aedes aegypti Technology 2019-06-03 20:30
International Medical Innovation and Cooperation Forum held in Fangchenggang City 2019-06-03 19:43
Updated Results on Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Squamous Non-Small Cell Lung Cancer (sqNSCLC) at ASCO, Led by Professor Jie He, Dean of the Cancer Hospital of the Chinese Academy of Medical Sciences 2019-06-03 08:00
1 378 379 380 381 382 493